CMX-2043, a novel, proprietary cytoprotective drug candidate, demonstrated excellent safety and tolerability in a Phase 1 single ascending and multiple ascending dose (SAD-MAD) clinical trial. CMX-2043 has previously demonstrated safety and efficacy in extensive preclinical pharmacology, toxicology and TBI translational studies. CMX-2043 will be Phase 2-ready by the first quarter of 2024.

As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its efforts.

The leading online ADHD treatment platform brings in Herman, who has more than two decades of managed care and pharmaceutical experience and is one of the leading experts in behavioral health.

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies

Online ADHD testing and assessment leader provides guidance for people managing symptoms of the disorders.

CEO Zach Booker also praises Midwest as haven for startups

The research opens the doors for promising applications that can help people with neurological diseases such as Parkinson's.

Leaders of online ADHD testing and assessment will discuss turning startups into long-term successes and what can be learned about mental health.

The industry's leader in ADHD assessment and treatment said telehealth will return to pre-pandemic rules when the Public Health Emergency expires on May 11.

The Dan Lewis Foundation for Brain Regeneration Research (the DLF) announces the 2023 DLF Prize.

The appointment further strengthens the company's scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria's approach for developing novel therapies for neurodegenerative and neuropsychiatric disorders.

The only zero-prep, full-montage, rapid EEG solution for clinical use now offers near real-time notification of ongoing seizures by using reliable FDA cleared seizure detection software

Guentzel and ADHD Online partner to publish a podcast episode every day during October, providing information and support while breaking down stigmas about ADHD and mental health.

The industry leader in online ADHD assessments is a finalist for the Excellence in Business category.

Project will use brain imaging and blood markers to detect the effects of Traumatic Brain Injury and distinguish them from Alzheimer's disease

ADHD Online alleviates overburdened system's long wait times for patients to receive ADHD assessments, treatments, and care

The National Institute of Health awards Cortechs.ai a multimillion grant to quantify microstructural changes in Alzheimer's Disease using Restriction Spectrum Imaging.

Providing this end-to-end solution will make EEGs accessible to any healthcare facility in the US

This service is available in real time upon request with a 30-minute notice 24/7/365.

Accomplished Former GE Chief Financial Officer Michi Sassa Joins Company

Novel NRCT-101SR shown in previous human studies to be effective and well-tolerated with no side effects

Brin to serve on National Advisory Neurological Disorders and Stroke Council

Recent advances in biomolecular medicine and biotechnology will make it possible for the injured brain to regenerate.

The nootropics site WholisticResearch just announced they bought the domain MyBrainTrainer.com, which was previously a virtual mental gym for brain exercises.